Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
8.88
-0.88 (-9.02%)
At close: Jan 26, 2026, 4:00 PM EST
8.88
0.00 (0.00%)
Pre-market: Jan 27, 2026, 5:55 AM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $507.31 million as of January 27, 2026. Its market cap has increased by 204.43% in one year.
Market Cap
507.31M
Enterprise Value
341.20M
1-Year Change
204.43%
Ranking
Category
Stock Price
$8.88
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $507.31M, a decrease of -43.51%. That is a compound annual growth rate of -25.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 557.58M | 3.83% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 535.07M |
| Lyell Immunopharma | 528.97M |
| Ocugen | 521.34M |
| Alto Neuroscience | 509.80M |
| Zevra Therapeutics | 507.80M |
| Solid Biosciences | 502.52M |
| Niagen Bioscience | 498.96M |
| Bicycle Therapeutics | 485.58M |